1. As of noon trading, Abbott Laboratories ( ABT) is down $0.43 (-0.7%) to $64.57 on light volume Thus far, 2.1 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 7.5 million shares. The stock has ranged in price between $64.46-$65.32 after having opened the day at $65.09 as compared to the previous trading day's close of $65.00. Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories has a market cap of $102.9 billion and is part of the drugs industry. The company has a P/E ratio of 15.9, below the S&P 500 P/E ratio of 17.7. Shares are up 15.6% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 11 rate it a hold. TheStreet Ratings rates Abbott Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Abbott Laboratories Ratings Report now. EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD). A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
Community Health Systems may close its $7.6 billion acquisition of Health Management Associates, but with the uncertainties of a new healthcare law and the merger partners' own legal problems, it needed good timing to put reasonable financing in place.